Is Your Trash Talk Violating The Code Of Ethics?

Is Your Trash Talk Violating The Code Of Ethics?

In these times, double down — on your skills, on your knowledge, on you. Join us Aug. 8-10 at Inman Connect Las Vegas to lean into the shift and learn from the best. Get your ticket now for the best price.

REALTORS shall not knowingly or recklessly make false or misleading statements about other real estate professionals, their businesses, or their business practices. (Amended 1/12)

Imagine you’re working with an agent or broker, either within your own brokerage or across the negotiating table. The two of you don’t see eye to eye, and you simply can’t stand the sight of this person. Now, you’re at happy hour, clutching onto anyone who’ll listen to talk about your dislike of this other Realtor and speculating on what nefarious misdeeds they’re (probably) up to.

Congratulations. You may have just violated the Realtor Code of Ethics. Article 15 lays out a comprehensive list of ways in which you must refrain from attacking the character or business practices of another Realtor.

Some of the specifics include:

  • Not initiating false or misleading statements about another Realtor, their business or their business practices (15-2)
  • Not passing on gossip that’s false or misleading about another Realtor, their business or their business practices (15-2)
  • Not posting false or misleading statements about another Realtor, their business or their business practices on social media nor passing them along in writing (via email or text, for example) (15-2)
  • Correcting false or misleading statements you’ve made in person or in writing once you’ve found out that they’re false or misleading (15-3)

You may think of Article 15 as being primarily about making statements to clients or potential clients about a competitor, and much of the case law pertains to this. However, the Article does not specify that, and much of the shit-talking that Realtors frequently engage in, whether in the office or socially, constitutes a potential violation.

There are many ways to run afoul of Article 15

While this part of the Code of Ethics isn’t more important than any other, it’s the one that we have the most control over — because we can control running our mouths. Furthermore, it impacts the reputation of the industry by undermining the professional reputation of both the speaker and the subject. 

In addition, Article 15 is probably the one that everyone has violated at one time or another. Whether you’ve told a “funny” story at a dinner party about what a friend-of-a-friend (incorrectly) said about an agent or you’ve hurled misleading accusations at a broker when leaving their brokerage, you’ve been in violation.

Remember, this is about more than agent-on-agent crime. It’s also brokers talking about the “weak link” in their brokerage. It’s team leaders complaining and speculating about an annoying team member. It’s agents who spread rumors about higher-ups in their organization out of a sense of grievance.

“Another issue we commonly see that agents aren’t always aware of is that many of the real estate portals out there are also Realtor members. We’ve all heard complaints about the portals, but these negative comments are Article 15 violations ever since the portals have become brokerages,” managing broker of California at Side and a local professional standards chair, Casey McLoed says.

What does it mean to be a professional under Article 15?

Everybody has personal preferences. Maybe there’s someone in your brokerage who just irritates you or someone you hate sitting across from at the closing table. Maybe there’s a big-time Realtor in your market who you feel has taken money out of your pocket. 

You’re allowed to dislike that person. You’re allowed to say they’re ugly or a bad dresser, whether to their face or behind their back. What you’re not allowed to do is falsely call them dishonest. Call them uncommitted to their job or their clients. Call them crooked or inept. All of these speak to their business and business practices.

Addressing it the right way

If you think someone has acted in a way that’s dishonest or that they’ve done something that’s against the law or the Code of Ethics, there are ways to address that.

File a complaint with their broker or with the Board of Realtors. If you wouldn’t take that step, if you couldn’t substantiate your allegations to that degree, you have no business passing that gossip along.

NAR provides extensive resources regarding the process for filing a complaint as well as the subsequent arbitration process. Before you run your mouth, check it out here.

One place Article 15 takes a beating is when a disgruntled agent is leaving a brokerage. They may take that as a free pass to say terrible things about the broker, the brokerage or the agents they worked with.

Resist this temptation.

If you have an issue with your broker or another agent, reach out to them directly. If it’s personal, address it — or get over it. If it’s professional, find out the process for filing a complaint or what internal process exists to address your concerns.

Most of all, be honest with yourself about the root of your problem.

Are you mad that the other agent is more successful than you are? Are you resentful that your production is down this year? Are you having personal problems that are making you overly sensitive and angry — then bleeding over into your professional perceptions?

Consider how trash-talking makes you look

Most of all, think about how talking this way makes you look: 

  • Think about how you look when you’ve had one too many and can’t stop talking. 
  • Think about what it says when you’re sending texts and emails around blasting another Realtor, especially if your allegations are demonstrably untrue. 
  • Think about the impact on your reputation if that Realtor decides to invoke Article 15 and file a complaint against you for your words and actions.

In the moment, you may think that you are justified, but playing the victim or being a gossip-monger will never make you look good. Consider whether broadcasting your personal grievance is going to be worse for you or the object of your wrath.

“Being heated or upset over a situation is something we all experience whether personally or professionally, McLoed said. “We all know that very regrettable statements or actions can be made in these situations as well. But you need to keep your composure in those scenarios.” 

McLoed tells agents to open an email — address it to themselves — write out their complaint or whatever thoughts they have, and then leave that email as a draft and wait a day before returning to it. 

“Now imagine this message sitting in front of the tribunal at an ethics hearing, or worse, projected up on the wall in a courtroom, then ask yourself: ‘Do I really want to say this? Do I really want my colleagues, my peers to see me communicate in this way?’” McLoed said. 

“The answer is no. You vented, but only to yourself, you’ve had time to cool down. Delete the draft, and continue on in a professional manner.”

If you think you’ve been the victim of an Article 15 violation

On the other side of the coin, if you have been the subject of an Article 15 violation, you may be considering filing a complaint. Talk to your manager first to find out if you have recourse within your brokerage and to determine what the process looks like. 

Talk to the representative at your local association, as well. Find out what evidence you’d need to prove your claim, and make sure you have it. You don’t want to file a grievance and then find out that you can’t make your charges stick.

Before you go through channels, you may want to explore other options, like a cease-and-desist letter from your attorney. In addition, if you have proof that the violation has had a material impact on your business and earnings, you may choose to seek legal recourse and compensation.

According to Sandra Miller, president of Engel & Völkers Santa Monica and a member of the professional standards committee, presiding officer, ethics advocate and mediator for the Greater Los Angeles Association of Realtors: “Agents should be held accountable for inappropriate behavior, and the only way to ensure that they are is to file an ethics complaint. Do not be afraid of the process, most of the country has adopted the usage of an ethics advocate who can walk you through the process. Call your local Association Professional Standards Administrator, and they will walk you through the process.”

Troy Palmquist is the founder and broker of DOORA Properties in Southern California. Follow him on Instagram or connect with him on LinkedIn.

Kelly Craft vows to dismantle Department of Education

Kelly Craft vows to dismantle Department of Education
Kelly Craft vows to dismantle Department of Education

Kelly Craft explained to an audience final 7 days that 1 of her 1st acts in office if she is elected as governor this 12 months will be to “dismantle” the Kentucky Section of Training.

The audio of Craft, who is running in a crowded discipline of candidates in the Republican primary, was presented by American Bridge 21st Century, a national Democratic PAC that sent a tracker to history her at her Feb. 2 campaign function in Versailles. Her campaign later confirmed the audio.

“I will explain to you that just one of the extremely 1st parts of action as governor, the Kentucky Department of Education will be dismantled,” Craft stated, adopted by applause from the viewers.

Changing channels | Business Travel News Europe

Changing channels | Business Travel News Europe

There is no scarcity of digital channels these days for individuals to interact with each individual other, either at get the job done or at enjoy. But travel managers (and their appointed journey administration businesses) can however wrestle to uncover the most efficient medium to communicate with travellers and travel arrangers.

“The technological innovation that vacation groups have to interact with their travellers hasn’t genuinely progressed at the similar level as systems like Slack,” suggests Adam Kerr, founder and CEO of Tripism. “One of our shoppers stated to me: ‘We have two kinds of traveller engagement. One particular is to deliver an email to 60,000 workers. The other is to adhere a PDF on the intranet where by no one particular will go through it’.”

Travel professionals have to be much more bold now, according to Mark Cuschieri, world head of travel at UBS. “Some travellers are operating from property, some in the office,” he says. “How do you get your concept across? It’s not just through one particular interaction asset. If you want to extend your achieve, you are heading to have to use a number of channels.” 

Electronic mail alone will not slash it, Cuschieri insists. “We connect with an electronic mail a tweemail right here,” he claims.

Kerr’s shopper was presumably exaggerating for impact when expressing the only alternatives were being electronic mail or intranet. Other possibilities have been about for a even though. One particular illustration is contextual mobile messages, which are sent to travellers at the suitable point of their journey – a reminder when their flight lands to take the practice fairly than a taxi from the airport to the city centre, for example.

“If you time them properly, you are not only heading to make the traveller joyful, you’re going to conserve funds,” claims Andy Menkes, founder and CEO of Partnership Vacation Consulting.

Contextual messaging is a typical aspect of cell apps provided by TMCs and other folks. However, these are travel-particular channels, not the a lot more standard communication platforms travellers use each working day. Some persons believe that requirements to modify.

“We have acquired that travellers want journey technologies to be exactly where they are at their desk or on the transfer,” states Katie Skitterall, team commercial director for ATPI, the multinational TMC. “The the greater part of our clients are in Microsoft Teams – or Slack if you are in the US – and WhatsApp in their personalized lives.

“Often you have received to go outside the house where by you are in purchase to e book or talk with your TMC. Other TMCs are striving to do it with their have chat functionality, which is a bit of a transform-off simply because you really don’t want to go somewhere else you want to be exactly where you are all the time.”

It is a philosophy that extends beyond communication. Concluding that many enterprises are, in Skitterall’s terms, “Microsoft houses”, ATPI is performing on a system to combine much of its client technological innovation into Microsoft, beginning with profile, itinerary, invoice and approval instruments pilots in excess of the future several months.

ATPI’s existence on Teams is previously up and jogging. One client employing the channel alongside electronic mail is the digital sports activities content and media group DAZN. “Teams is a chat functionality,” states worldwide travel supervisor Kim Trenter. “It’s great for a rapid problem since people today are not in the office environment that substantially any additional when they may well question you over the water cooler.”

Teams is an enterprise comms platform but ATPI believes in partaking by personal channels too, specially for personnel arranging their vacation exterior standard performing hours. Appropriately, ATPI now communicates through WhatsApp too.


Any time you are pushing individually identifiable details or enterprise proprietary info, you probably have to get approval from corporate safety


Trenter loves the concept. “In some marketplaces like India and Brazil we previously connect in just the business by way of WhatsApp,” she states. “I know a couple of firms which have rolled out WhatsApp with their TMC and discovered that actually prosperous, so with any luck , we’ll be doing that about the upcoming quarter. ATPI presently has the capacity to do it. It is just a concern of creating guaranteed our protection staff can approve it.”

Engagement is not just about chat, even so. It also involves supplying expertise resources this kind of as vacation policy, insurance plan specifics and directions for new workers. DAZN residences all this details on Microsoft collaborative system SharePoint, even though other corporations generally do so on their standard employee intranets.

Tripism’s Kerr argues all these kinds of platforms are way too static and inadequately configured to the individual requires of traveller engagement. At the identical time, he suggests, engagement has turn out to be a a lot more intricate, specialised job for two factors. The to start with is that there is a ton much more to interact about than a decade back: sustainability and wellbeing, for illustration. The next is that companies ordinarily have much additional travel companions.

Kerr also observes the development for enterprises to go to professional platforms for other business features, these kinds of as Workday for HR and Coupa for procurement. He introduced Tripism to fill the gap he describes. “We imagine traveller information and engagement has grow to be so advanced and sophisticated that you now need a specialist platform,” he says.

Tripism purchasers consist of Barclays, Nike, Oracle and, curiously, Microsoft, perhaps reinforcing the position that traveller engagement requires far more than a blend of Groups, e-mail and SharePoint. The Tripism offering incorporates customised content this sort of as positive aspects and promotions summaries for the client’s most well-liked suppliers, plus location and vacation programme facts and suggestions from travellers, like hotel evaluations and travel strategies, as effectively as surveys of their excursion knowledge.

“Every time another person returns from vacation they get a concept asking them to charge every single section of their journey,” says Cuschieri, a Tripism buyer. “If there was an situation, an automatic electronic mail goes to the respective regional head and we act upon it within just 24 several hours. That is what our travellers like: they know that they will often get a reaction. We are equipped to measure the functionality of every single part of the journey and we know where we possibly have pain factors.”

Supplied that UBS runs Tripism alongside other details resources such as its agency mobile app, an apparent chance with deploying many platforms, such as 1 solely for traveller engagement, is fragmentation and inconsistency. Therefore, Cuschieri warns, a key need for a effective omnichannel method is good interconnectivity.

“From any asset you can go to someplace else,” he says. “If you are on Tripism and have to have to know what our vacation plan is, you can go to our journey plan. Our online reserving tool also has the means to ping again to all our portals. We replicate our messaging or we drive individuals concerning the platforms, so anywhere you are you can constantly get to where you need to have, whether or not it is to make a scheduling, appear at our resort programme, make a evaluate or chat to an agent. This does make it a lot a lot more complicated but there is no 1 system we feel will suffice.”

A further very important multi-system thought is protection. “Any time you are pushing personally identifiable information and facts or enterprise proprietary facts, you probably have to get approval from company safety,” states Menkes. “The minute a PNR is up in the ether it is good sport except it is guarded.”

Skitterall suggests suitable precautions can be taken. For instance, ATPI would not take photos from travellers of their passports on WhatsApp. Instead, it would mail a url to a protected web page exactly where the image could be uploaded.

But most likely the most critical suggestions of all, appropriately ample for an engagement tactic, is to interact with stakeholders about that strategy ahead of embarking on it. “It sounds seriously primary but I just check with journey bookers and vital travellers what kind of communication they want as a substitute of giving them what I believe they want,” claims Trenter.

For now the solution to Trenter’s query is Groups and WhatsApp, but what following? TikTok and Snapchat anyone? “Why not?” suggests Skitterall, adding that it is only a make any difference of time just before the generation which utilizes this sort of platforms turn into business travellers by themselves. “All these up-and-coming social platforms – we’re going to want to be there,” she claims.

Harry Styles’ Grammy fashion: Rainbow jumpsuit divides social media

Harry Styles’ Grammy fashion: Rainbow jumpsuit divides social media

Created by Oscar Holland, CNN

Harry Styles experienced a night time to keep in mind. Not only did he take home two Grammy Awards on Sunday evening, but he also served up some of the ceremony’s most talked-about outfits.

The previous A person Route star began the night in a plunging technicolor jumpsuit that revealed a collection of butterfly and fowl tattoos on his otherwise bare upper body. The vibrant harlequin sample was brought to lifestyle by Swarovski crystals, though the legs of the sparkling garment flared out in excess of a pair of white boots.

Harry Styles in a rainbow-colored harlequin jumpsuit by Egonlab and Swarovski.

Harry Variations in a rainbow-coloured harlequin jumpsuit by Egonlab and Swarovski. Credit rating: Amy Sussman/Getty Visuals

Even though Types typically opts for red-carpet looks — and without a doubt jumpsuits — by Italian label Gucci, this just one was intended by Egonlab, an rising French manufacturer regarded for its genderless creations.

The outfit divided social media, with comments ranging from “he can pretty much dress in anything at all” to “appears to be like he forgot the jacket.” Some others dubbed the look an illustration of “clowncore,” while the singer also drew comparisons — the two favorable and disparaging — to two of Britain’s most flamboyant pop icons: Elton John and David Bowie.

Jumpsuits have turn into a little something of a signature glance for Models, who consistently wore them on phase through his Enjoy On Tour. It was no shock, hence, that he experienced a next a single all set for his much-anticipated Grammys efficiency.

Harry Styles in jumpsuit number two as he performs "As it Was."

Harry Styles in jumpsuit quantity two as he performs “As it Was.” Credit: Mario Anzuoni/Reuters

Using the stage for a rendition of strike track “As It Was” (which you may possibly bear in mind showcased a online video of the singer donning a — you guessed it — sequined purple jumpsuit), the star opted for a considerably less revealing, even though no significantly less exuberant, selection.

The overall performance drew a standing ovation from Taylor Swift, and his silver fringed structure gained plaudits online, too, although Twitter customers also when compared it to a embellished Xmas tree and a pair of metallic fringe curtains.
Harry Styles accepts the Best Pop Vocal Album award for "Harry's House."

Harry Kinds accepts the Very best Pop Vocal Album award for “Harry’s House.” Credit: JC Olivera/WireImage/Getty Pictures

Variations, who is recognized for daring and gender-fluid manner, opted for a little something a lot more official to collect his awards. Getting the stage to scoop up the coveted Album of the 12 months and Greatest Pop Vocal Album for “Harry’s Residence,” he appeared dapper in a cropped white accommodate jacket and wide-legged tan-colored trousers.

Even then, he couldn’t assistance but deliver some sparkle to the outfit in a shimmering reduced-lower top.

Lumen Technologies reports fourth quarter 2022 results

Lumen Technologies reports fourth quarter 2022 results

Fourth Quarter 2022 Highlights

  • Appointed Kate Johnson as president, chief executive officer, and a member of the company’s Board of Directors
  • Completed the $7.5 billion divestiture of its 20-state ILEC business to Apollo on Oct. 3
  • Announced an exclusive arrangement for the proposed sale of its EMEA business to Colt Technology Services for $1.8 billion
  • Repurchased 33 million shares of common stock for a total purchase price of $200 million
  • Reported Net Loss of $(3.069) billion for the fourth quarter 2022, which included a non-cash goodwill impairment charge of $3.271 billion, compared to reported Net Income of $508 million for the fourth quarter 2021
  • Reported diluted loss per share of ($3.08) for the fourth quarter 2022, compared to diluted earnings per share of $0.50 for the fourth quarter 2021. Excluding Special Items, Diluted EPS of $0.43 per share for the fourth quarter 2022, compared to $0.51 per share for the fourth quarter 2021
  • Generated Adjusted EBITDA of $1.393 billion for the fourth quarter 2022, compared to $2.088 billion for the fourth quarter 2021, excluding the effects of Special Items of $583 million and $19 million, respectively
  • Generated Modified1 Adjusted EBITDA of $1.393 billion for the fourth quarter 2022, compared to $1.496 billion for the fourth quarter 2021, excluding the effects of Special Items of $583 million and $19 million, respectively
  • Reported Net Cash Provided by Operating Activities of $841 million for the fourth quarter 2022
  • Generated Free Cash Flow of $126 million for the fourth quarter 2022, compared to $776 million for the fourth quarter 2021, excluding cash paid for Special Items of $118 million and $17 million, respectively

_____________________________________________

1 Modified amounts include adjustments to reflect (i) removal of the financial impacts related to the Latin American business divestiture completed Aug. 1, 2022 and the 20-state ILEC business divestiture completed Oct. 3, 2022, (ii) estimates of revenue that Lumen would have received under the post-closing agreements with the purchasers of the divested businesses, and (iii) removal of the financial impacts of the Federal Communications Commission’s Connect America Fund (“CAF”) Phase II program, which lapsed on Dec. 31, 2021, each excluding the effects of special items. Reconciliation of these non-GAAP financial measures to the most directly comparable GAAP measures are provided in the Financial Trending Schedule available on Lumen’s website at ir.lumen.com, along with additional modified information reported on this basis.


Full Year 2022 Financial Highlights

  • Generated $10.2 billion of gross proceeds from business divestitures2
  • Reduced Estimated Net Debt3 by $9.9 billion
  • Reported Net Loss of $(1.548) billion for the full year 2022, which included a non-cash goodwill impairment charge of $3.271 billion, compared to reported Net Income of $2.033 billion for the full year 2021
  • Reported diluted loss per share of ($1.54) for the full year 2022, compared to diluted earnings per share of $1.91 for the full year 2021. Excluding Special Items, Diluted EPS of $1.55 per share for the full year 2022, compared to $1.91 per share for the full year 2021
  • Generated Adjusted EBITDA of $6.858 billion for the full year 2022, compared to $8.440 billion for the full year 2021, excluding the effects of Special Items of $155 million and $16 million, respectively
  • Generated Modified1 Adjusted EBITDA of $5.540 billion for the full year 2022, compared to $6.092 billion for the full year 2021, excluding the effects of Special Items of $155 million and $16 million, respectively
  • Reported Net Cash Provided by Operating Activities of $4.735 billion for the full year 2022
  • Delivered Free Cash Flow of $2.260 billion for the full year 2022, compared to $3.742 billion for the full year 2021, excluding cash paid for Special Items of $541 million and $141 million, respectively

DENVER, Feb. 7, 2023 /PRNewswire/ — Lumen Technologies, Inc. (NYSE: LUMN) reported results for the fourth quarter ended December 31, 2022.

“This year brings significant change for Lumen as we pivot to growth with a new leadership team and an energized group of highly skilled employees to execute on our plan,” said Kate Johnson, president and CEO of Lumen. “In 2023 we will be investing in and optimizing Lumen as we drive our five core priorities: develop customer obsession, innovate and invest for growth, build a reliable execution engine, radically simplify Lumen, and further develop our culture.”

Total Revenue was $3.800 billion for the fourth quarter 2022, compared to $4.847 billion for the fourth quarter 2021 and compared to Modified1 Revenue of $4.022 billion for the fourth quarter 2021.

_______________________________________________

1 Modified amounts include adjustments to reflect (i) removal of the financial impacts related to the Latin American business divestiture completed Aug. 1, 2022 and the 20-state ILEC business divestiture completed Oct. 3, 2022, (ii) estimates of revenue that Lumen would have received under the post-closing agreements with the purchasers of the divested businesses, and (iii) removal of the financial impacts of the Federal Communications Commission’s Connect America Fund (“CAF”) Phase II program, which lapsed on Dec. 31, 2021, each excluding the effects of special items. Reconciliation of these non-GAAP financial measures to the most directly comparable GAAP measures are provided in the Financial Trending Schedule available on Lumen’s website at ir.lumen.com, along with additional modified information reported on this basis.


2 For the 20-state ILEC business divestiture, we received $7.5 billion of consideration, which was reduced by approximately $0.4 billion of closing adjustments and partially paid through purchaser’s assumption of approximately $1.5 billion of our long-term consolidated indebtedness, resulting in pre-tax cash proceeds of approximately $5.6 billion. For the Latin American business divestiture, we received pre-tax cash proceeds of approximately $2.7 billion.


3 During the first half of 2023, we expect to pay approximately $900 million to $1 billion of cash taxes related to the 2022 divestitures of our Latin American and 20-state ILEC businesses. To provide comparability to prior periods, Estimated Net Debt reflects the payment of those cash taxes as though it had occurred on or prior to Dec. 31, 2022.


Financial Results

Metric, as reported

Fourth Quarter

Full Year

($ in millions, except per share data)

2022

2021

2022

2021

International and Global Accounts

$    797

1,025

$  3,645

4,083

Large Enterprise

804

931

3,409

3,771

Mid-Market Enterprise

585

647

2,465

2,649

Enterprise Channels

2,186

2,603

9,519

10,503

Wholesale

819

891

3,520

3,616

Business Segment Revenue

3,005

3,494

13,039

14,119

Mass Markets Segment Revenue

795

1,353

4,439

5,568

Total Revenue

$  3,800

4,847

$ 17,478

19,687

Cost of Services and Products

1,826

2,086

7,868

8,488

Selling, General and Administrative Expenses

671

723

3,078

2,895

Gain on Sale of Businesses(1)

(180)

—

(773)

—

Loss on disposal groups held for sale

700

—

700

—

Stock-based Compensation Expense

27

31

98

120

Adjusted EBITDA(2)

810

2,069

6,703

8,424

Adjusted EBITDA, Excluding Special Items(2)(3)

1,393

2,088

6,858

8,440

Adjusted EBITDA Margin(2)

21.3 {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

42.7 {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

38.4 {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

42.8 {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

Adjusted EBITDA Margin, Excluding Special Items(2)(3)

36.7 {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

43.1 {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

39.2 {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

42.9 {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

Net Cash Provided by Operating Activities

841

1,607

4,735

6,501

Capital Expenditures

833

848

3,016

2,900

Unlevered Cash Flow(2)

264

1,100

3,059

5,086

Unlevered Cash Flow, Excluding Cash Special Items(2)(4)

382

1,117

3,600

5,227

Free Cash Flow(2)

8

759

1,719

3,601

Free Cash Flow, Excluding Cash Special Items(2)(4)

126

776

2,260

3,742

Net (Loss) Income

(3,069)

508

(1,548)

2,033

Net Income, Excluding Special Items(2)(5)

425

522

1,564

2,039

Net Income per Common Share – Diluted

(3.08)

0.50

(1.54)

1.91

Net Income per Common Share – Diluted, Excluding Special Items(2)(5)

0.43

0.51

1.55

1.91

Weighted Average Shares Outstanding (in millions) – Diluted

995.6

1,015.5

1,007.5

1,066.8






(1) Reflects (i) the pre-tax gain of $597 million recorded in operating income as a result of our Latin American business divestiture completed Aug. 1, 2022 and (ii) the pre-tax gain of $176 million recorded in operating income as a result of our 20-state ILEC business divestiture completed Oct. 3, 2022, subject to certain post-closing adjustments.

(2) See the attached schedules for definitions of non-GAAP metrics and reconciliations to GAAP figures.

(3) Excludes Special Items in the amounts of (i) $583 million for the fourth quarter of 2022, (ii) $19 million for the fourth quarter of 2021, (iii) $155 million for the full year 2022 and (iv) $16 million for the full year 2021.

(4) Excludes cash paid for Special Items of (i) $118 million for the fourth quarter of 2022, (ii) $17 million for the fourth quarter of 2021, (iii) $541 million for the full year 2022 and (iv) $141 million for the full year 2021.

(5) Excludes Special Items (net of the income tax effect thereof) in the amounts of (i) $3.5 billion for the fourth quarter of 2022, (ii) $14 million for the fourth quarter of 2021, (iii) $3.1 billion for the full year 2022 and (iv) $6 million for the full year 2021.

Modified(1) Metrics

Fourth Quarter

YoY
Percent

Full Year

YoY
Percent

($ in millions)

2022

2021

Change

2022

2021

Change

Revenue By Sales Channel







Large Enterprise

$  1,217

1,272

(4) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

$  4,894

5,106

(4) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

Mid-Market Enterprise

522

559

(7) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

2,144

2,297

(7) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

Public Sector

431

500

(14) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

1,788

1,997

(10) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

Enterprise Channels

2,170

2,331

(7) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

8,826

9,400

(6) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

Wholesale

835

831

— {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

3,360

3,385

(1) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

Business Segment Revenue

3,005

3,162

(5) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

12,186

12,785

(5) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

Mass Markets Segment Revenue

795

860

(8) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

3,302

3,554

(7) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

Total Revenue

$  3,800

4,022

(6) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

$ 15,488

16,339

(5) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

Adjusted EBITDA, Excluding Special Items

$  1,393

1,496

(7) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

$  5,540

6,092

(9) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

Adjusted EBITDA Margin, Excluding Special Items

36.7 {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

37.2 {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

(1) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

35.8 {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

37.3 {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

(4) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

Capital Expenditures

$    833

681

22 {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

$  2,691

2,325

16 {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}


(1) Modified amounts include adjustments to reflect (i) removal of the financial impacts related to the Latin American business divestiture completed Aug. 1, 2022 and the 20-state ILEC business divestiture completed Oct. 3, 2022, (ii) estimates of revenue that Lumen would have received under the post-closing agreements with the purchasers of the divested businesses, and (iii) removal of the financial impacts of the Federal Communications Commission’s Connect America Fund (“CAF”) Phase II program, which lapsed on Dec. 31, 2021, each excluding the effects of special items. Reconciliation of these non-GAAP financial measures to the most directly comparable GAAP measures are provided in the Financial Trending Schedule available on Lumen’s website at ir.lumen.com, along with additional modified information reported on this basis.


Cash Flow
Free Cash Flow, excluding Special Items, was $126 million in the fourth quarter 2022, compared to $776 million in the fourth quarter 2021.

As of Dec. 31, 2022, Lumen had cash and cash equivalents of $1.251 billion.

Goodwill Impairment
Each year, the company is required under GAAP to undertake a goodwill impairment analysis of all its reporting units. The analysis compares the fair value of the equity for each of the reporting units to the carrying value of equity for each reporting unit. The analysis takes into account weighted average cost of capital and market multiples, along with the company’s forecasts. Based on this analysis, in the fourth quarter of 2022 the company recorded an aggregate $3.271 billion non-cash goodwill impairment, primarily in our North America business reporting unit.

Update on the Divestiture of EMEA Business to Colt
Since we announced this transaction on Nov. 2, 2022, Colt has exercised its option to acquire our EMEA business following the completion of a French consultative process. The parties expect to enter into a definitive purchase agreement in the next couple of days. We expect to close this transaction on the terms previously announced as early as late 2023, following receipt of all requisite regulatory approvals in the U.S. and certain other countries where the EMEA business operates, as well as the satisfaction of other customary conditions.

2023 Financial Outlook

The company announced its full-year 2023 financial outlook which is detailed below:

Metric (1)(2)

Outlook(3)

Adjusted EBITDA

$4.6 to $4.8 billion

Free Cash Flow(4)(5)

$0 to $200 million

Net Cash Interest

$1.1 to $1.2 billion

GAAP Interest Expense

$1.200 billion

Capital Expenditures

$2.9 to $3.1 billion

Depreciation and Amortization

$2.9 to $3.1 billion

Stock-based Compensation Expense

~$125 million

Cash Income Taxes(5)

~$200 to $300 million

Full Year Effective Income Tax Rate

~26{515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}



(1)  For definitions of non-GAAP metrics and reconciliations to GAAP figures, see the attached schedules and our Investor Relations website.

(2)  Outlook measures in this chart and the accompanying schedules (i) exclude the effects of Special Items, future changes in our operating or capital allocation plans, unforeseen changes in regulation, laws or litigation, and other unforeseen events or circumstances impacting our financial performance and (ii) speak only as of Feb. 7, 2023. See “Forward-Looking Statements.”

(3)  Includes accounting impacts of assets and liabilities held for sale and assumes the proposed sale of Lumen’s EMEA business is not completed during 2023.

(4)  Assumes no discretionary pension plan contributions during 2023.

(5)  Excludes the estimated $900 million to $1 billion impact of taxes related to our divestitures completed on Aug. 1, 2022 and Oct. 3, 2022.


Investor Call

Lumen’s management team will host a conference call at 5:00 p.m. ET today, Feb. 7, 2023. The conference call will be streamed live over the Lumen website at ir.lumen.com. Additional information regarding fourth quarter 2022 results, including the presentation materials management will review during the conference call, will be available on the Investor Relations website prior to the call. If you are unable to join the call via the web, the call can be accessed live at +1 877-283-5145 (U.S. Domestic) or +1 312-281-1201 (International).

A telephone replay of the call will be available beginning at 8:00 p.m. ET on Feb. 7, 2023, and ending May 8, 2023, at 8:00 p.m. ET. The replay can be accessed by dialing +1 800-633-8284 (U.S. Domestic) or +1 402-977-9140 (International), reservation code 22024860. A webcast replay of the call will also be available on our website beginning at 8:00 p.m. ET on Feb. 7, 2023, and ending May 8, 2023, at 8:00 p.m. ET.

About Lumen Technologies and the People of Lumen:

Lumen Technologies Inc. (NYSE: LUMN) is guided by our belief that humanity is at its best when technology advances the way we live and work. With approximately 400,000 route fiber miles and serving customers in more than 60 countries, we deliver the fastest, most secure platform for applications and data to help businesses, government and communities deliver amazing experiences.

Learn more about the Lumen network, edge cloud, security, communication and collaboration solutions and our purpose to further human progress through technology at news.lumen.com, LinkedIn: /lumentechnologies, Twitter: @lumentechco, Facebook: /lumentechnologies, Instagram: @lumentechnologies and YouTube: /lumentechnologies. Lumen and Lumen Technologies are registered trademarks of Lumen Technologies LLC in the United States. Lumen Technologies LLC is a wholly-owned affiliate of Lumen Technologies, Inc. 

Forward-Looking Statements

Except for historical and factual information, the matters set forth in this release and other of our oral or written statements identified by words such as “estimates,” “expects,” “anticipates,” “believes,” “plans,” “intends,” “will,” and similar expressions are forward-looking statements as defined by the federal securities laws, and are subject to the “safe harbor” protections thereunder. These forward-looking statements are not guarantees of future results and are based on current expectations only, are inherently speculative, and are subject to a number of assumptions, risks and uncertainties, many of which are beyond our control. Actual events and results may differ materially from those anticipated, estimated, projected or implied by us in those statements if one or more of these risks or uncertainties materialize, or if underlying assumptions prove incorrect. Factors that could affect actual results include but are not limited to: the effects of intense competition from a wide variety of competitive providers, including decreased demand for our more mature service offerings and increased pricing pressures; the effects of new, emerging or competing technologies, including those that could make our products less desirable or obsolete; our ability to successfully and timely attain our key operating imperatives, including simplifying and consolidating our network, simplifying and automating our service support systems, attaining our Quantum Fiber buildout plans, strengthening our relationships with customers and attaining projected cost savings; our ability to safeguard our network, and to avoid the adverse impact of possible cyber-attacks, security breaches, service outages, system failures, or similar events impacting our network or the availability and quality of our services; the effects of ongoing changes in the regulation of the communications industry, including the outcome of legislative, regulatory or judicial proceedings relating to content liability standards, intercarrier compensation, universal service, service standards, broadband deployment, data protection, privacy and net neutrality; our ability to generate cash flows sufficient to fund our financial commitments and objectives, including our capital expenditures, operating costs, debt repayments, pension contributions and other benefits payments; our ability to effectively retain and hire key personnel and to successfully negotiate collective bargaining agreements on reasonable terms without work stoppages; changes in customer demand for our products and services, including increased demand for high-speed data transmission services; our ability to successfully maintain the quality and profitability of our existing product and service offerings and to introduce profitable new offerings on a timely and cost-effective basis; our ability to successfully and timely implement our corporate strategies, including our deleveraging and buildout strategies; our ability to successfully and timely consummate the pending divestiture of our European, Middle Eastern and African business, to successfully and timely realize the anticipated benefits from that divestiture and our divestitures completed in 2022, and to successfully operate and transform our retained business after such divestitures; changes in our operating plans, corporate strategies, or capital allocation plans, whether based upon changes in our cash flows, cash requirements, financial performance, financial position, market or regulatory conditions, or otherwise; the impact of any future material acquisitions or divestitures that we may transact; the negative impact of increases in the costs of our pension, healthcare, post-employment or other benefits, including those caused by changes in markets, interest rates, mortality rates, demographics or regulations; the potential negative impact of customer complaints, government investigations, security breaches or service outages impacting us or our industry; adverse changes in our access to credit markets on favorable terms, whether caused by changes in our financial position, lower credit ratings, unstable markets or otherwise; our ability to meet the terms and conditions of our debt obligations and covenants, including our ability to make transfers of cash in compliance therewith; our ability to maintain favorable relations with our security holders, key business partners, suppliers, vendors, landlords and financial institutions; our ability to timely obtain necessary hardware, software, equipment, services, governmental permits and other items on favorable terms; our ability to meet evolving environmental, social and governance (“ESG”) expectations and benchmarks, and effectively communicate and implement our ESG strategies; our ability to collect our receivables from, or continue to do business with, financially-troubled customers; our ability to continue to use or renew intellectual property used to conduct our operations; any adverse developments in legal or regulatory proceedings involving us; changes in tax, pension, healthcare or other laws or regulations, in governmental support programs, or in general government funding levels, including those arising from recently enacted legislation promoting broadband development; our ability to use our net operating loss carryforwards in the amounts projected; the effects of changes in accounting policies, practices or assumptions, including changes that could potentially require additional future impairment charges; continuing uncertainties regarding the impact that COVID-19 and its aftermath could have on our business, operations, cash flows and corporate initiatives; the effects of adverse weather, terrorism, epidemics, pandemics, rioting, vandalism, societal unrest, or other natural or man-made disasters or disturbances; the potential adverse effects if our internal controls over financial reporting have weaknesses or deficiencies, or otherwise fail to operate as intended; the effects of changes in interest rates and inflation; the effects of more general factors such as changes in exchange rates, in operating costs, in public policy, in the views of financial analysts, or in general market, labor, economic or geopolitical conditions; and other risks referenced from time to time in our filings with the U.S. Securities and Exchange Commission. You are cautioned not to unduly rely upon our forward-looking statements, which speak only as of the date made. We undertake no obligation to publicly update or revise any forward-looking statements for any reason, whether as a result of new information, future events or developments, changed circumstances, or otherwise. Furthermore, any information about our intentions contained in any of our forward-looking statements reflects our intentions as of the date of such forward-looking statement, and is based upon, among other things, regulatory, technological, industry, competitive, economic and market conditions, and our related assumptions, as of such date. We may change our intentions, strategies or plans without notice at any time and for any reason.

Reconciliation to GAAP

This release includes certain historical and forward-looking non-GAAP financial measures, including but not limited to Modified Revenue, Modified Adjusted Revenue, Adjusted EBITDA, Modified Adjusted EBITDA, Free Cash Flow, Unlevered Cash Flow, and adjustments to GAAP and non-GAAP measures to exclude the effect of Special Items. This release also includes certain modified historical information, none of which has been prepared in accordance with Regulation S-X promulgated by the U.S. Securities and Exchange Commission.

In addition to providing key metrics for management to evaluate the company’s performance, we believe these above-described measurements assist investors in their understanding of period-to-period operating performance and in identifying historical and prospective trends.

Reconciliations of non-GAAP financial measures to the most comparable GAAP measures are included in the attached financial schedules. Reconciliation of modified historical information appearing herein and additional non-GAAP historical financial measures that may be discussed during the call described above, along with further descriptions of non-GAAP financial measures, will be available in the Investor Relations portion of the company’s website at http://ir.lumen.com. Non-GAAP measures are not presented to be replacements or alternatives to the GAAP measures, and investors are urged to consider these non-GAAP measures in addition to, and not in substitution for, measures prepared in accordance with GAAP. Lumen may present or calculate its non-GAAP measures differently from other companies.

Lumen Technologies, Inc.

CONSOLIDATED STATEMENTS OF OPERATIONS

THREE AND TWELVE MONTHS ENDED DECEMBER 31, 2022 AND 2021

(UNAUDITED)

($ in millions, except per share amounts; shares in thousands)



Three months ended
December 31,


(Decrease)
/ Increase


Twelve months ended
December 31,


(Decrease)
/ Increase



2022


2021



2022


2021


OPERATING REVENUE


$        3,800


4,847


(22) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}


17,478


19,687


(11) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

OPERATING EXPENSES













Cost of services and products (exclusive of depreciation and amortization)


1,826


2,086


(12) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}


7,868


8,488


(7) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

Selling, general and administrative


671


723


(7) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}


3,078


2,895


6 {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

Gain on sale of businesses


(180)


—


nm


(773)


—


nm

Loss on disposal groups held for sale


700


—


nm


700


—


nm

Depreciation and amortization


796


877


(9) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}


3,239


4,019


(19) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

Goodwill impairment


3,271


—


nm


3,271


—


nm

Total operating expenses


7,084


3,686


92 {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}


17,383


15,402


13 {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

OPERATING (LOSS) INCOME


(3,284)


1,161


nm


95


4,285


(98) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

OTHER (EXPENSE) INCOME













Interest expense


(280)


(372)


(25) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}


(1,332)


(1,522)


(12) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

Other income (expense), net


382


(110)


nm


246


(62)


nm

Income tax benefit (expense)


113


(171)


(166) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}


(557)


(668)


(17) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

NET (LOSS) INCOME


$      (3,069)


508


nm


$       (1,548)


2,033


(176) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}








BASIC (LOSS) EARNINGS PER SHARE


$        (3.08)


0.50


nm


(1.54)


1.92


(180) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

DILUTED (LOSS) EARNINGS PER SHARE


$        (3.08)


0.50


nm


(1.54)


1.91


(181) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}








WEIGHTED AVERAGE SHARES OUTSTANDING













Basic


995,573


1,006,846


(1) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}


1,007,517


1,059,541


(5) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

Diluted


995,573


1,015,472


(2) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}


1,007,517


1,066,778


(6) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

DIVIDENDS PER COMMON SHARE


$              —


0.25


(100) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}


0.75


1.00


(25) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}








Exclude: Special Items(1)


$        3,494


14


nm


3,112


6


nm

NET INCOME EXCLUDING SPECIAL ITEMS


$           425


522


(19) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}


1,564


2,039


(23) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

DILUTED EARNINGS PER SHARE EXCLUDING SPECIAL ITEMS


$          0.43


0.51


(16) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}


1.55


1.91


(19) {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}








(1) Excludes the Special Items described in the accompanying Non-GAAP Special Items table, net of the income tax effect thereof.

nm – Percentages greater than 200{515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502} and comparisons between positive and negative values are considered not meaningful.

Lumen Technologies, Inc.

CONSOLIDATED BALANCE SHEETS

AS OF DECEMBER 31, 2022 AND DECEMBER 31, 2021

(UNAUDITED)

($ in millions)


December 31, 2022


December 31, 2021

ASSETS




CURRENT ASSETS




Cash and cash equivalents

$                     1,251


354

Accounts receivable, less allowance of $85 and $114

1,477


1,544

Assets held for sale

1,889


8,809

Other

803


829

   Total current assets

5,420


11,536

Property, plant and equipment, net of accumulated depreciation of $19,886 and $19,271

19,166


20,895

GOODWILL AND OTHER ASSETS




Goodwill

12,657


15,986

Other intangible assets, net

6,166


6,970

Other, net

2,172


2,606

    Total goodwill and other assets

20,995


25,562

TOTAL ASSETS

$                   45,581


57,993

LIABILITIES AND STOCKHOLDERS’ EQUITY




CURRENT LIABILITIES




Current maturities of long-term debt

$                        154


1,554

Accounts payable

950


758

Accrued expenses and other liabilities




Salaries and benefits

692


860

Income and other taxes

1,158


228

Current operating lease liabilities

344


385

Interest

181


278

Other

277


232

Liabilities held for sale

451


2,257

Current portion of deferred revenue

596


617

    Total current liabilities

4,803


7,169

LONG-TERM DEBT

20,418


27,428

DEFERRED CREDITS AND OTHER LIABILITIES




Deferred income taxes, net

3,163


4,049

Benefit plan obligations, net

2,391


3,710

Other

4,369


3,797

Total deferred credits and other liabilities

9,923


11,556

STOCKHOLDERS’ EQUITY




Common stock

1,002


1,024

Additional paid-in capital

18,080


18,972

Accumulated other comprehensive loss

(1,099)


(2,158)

Accumulated deficit

(7,546)


(5,998)

Total stockholders’ equity

10,437


11,840

TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY

$                   45,581


57,993

Lumen Technologies, Inc.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

TWELVE MONTHS ENDED DECEMBER 31, 2022 AND 2021

(UNAUDITED)

($ in millions)


Twelve months ended


December 31, 2022


December 31, 2021

OPERATING ACTIVITIES




Net (Loss) Income

$                             (1,548)


2,033

Adjustments to reconcile net (loss) income to net cash provided by operating activities:




Depreciation and amortization

3,239


4,019

Goodwill impairment

3,271


—

Gain on sale of businesses

(773)


—

Loss on disposal groups held for sale

700


—

Deferred income taxes

(1,230)


598

Provision for uncollectible accounts

133


105

Net gain on early retirement of debt

(214)


(8)

Unrealized loss on investments

191


(138)

Stock-based compensation

98


120

Changes in current assets and liabilities, net

540


(691)

Retirement benefits

46


163

Changes in other noncurrent assets and liabilities, net

258


283

Other, net

24


17

Net cash provided by operating activities

4,735


6,501

INVESTING ACTIVITIES




Capital expenditures

(3,016)


(2,900)

Proceeds from sale of businesses

8,369


—

Proceeds from sale of property, plant and equipment and other assets

120


135

Other, net

3


53

Net cash used in investing activities

5,476


(2,712)

FINANCING ACTIVITIES




Net proceeds from issuance of long-term debt

—


1,881

Payments of long-term debt

(8,093)


(3,598)

Net (payments on) proceeds from revolving line of credit

(200)


50

Dividends paid

(780)


(1,087)

Repurchases of common stock

(200)


(1,000)

Other, net

(40)


(53)

Net cash used in financing activities

(9,313)


(3,807)

Net increase in cash, cash equivalents and restricted cash

898


(18)

Cash, cash equivalents and restricted cash at beginning of period

409


427

Cash, cash equivalents and restricted cash at end of period

$                               1,307


409





Cash, cash equivalents and restricted cash:




Cash and cash equivalents

$                               1,251


354

Cash and cash equivalents and restricted cash included in assets held for sale

44


40

Restricted cash

12


15

Total

$                               1,307


409

Lumen Technologies, Inc.

MODIFIED(1) OPERATING METRICS

(UNAUDITED)







Operating Metrics

4Q22


3Q22


4Q21







Mass Markets broadband subscribers






(in thousands)






Fiber broadband subscribers

832


813


735

Other broadband subscribers(2)

2,205


2,294


2,555

Mass Markets total broadband subscribers(3)

3,037


3,107


3,290







Mass Markets broadband enabled units(4)






(in millions)






Fiber broadband enabled units

3.1


3.0


2.5

Other broadband enabled units

18.7


18.8


18.8

Mass Markets total broadband enabled units

21.8


21.8


21.3







(1) Modified to remove the impacts of the 20-state ILEC business divestiture completed Oct. 3, 2022.

(2) Other broadband subscribers are customers that primarily subscribe to lower speed copper-based broadband services marketed under the CenturyLink brand.

(3) Mass Markets broadband subscribers are customers that purchase broadband connection service through their existing telephone lines, stand-alone telephone lines, or fiber-optic cables. Our methodology for counting our Mass Markets broadband subscribers includes only those lines that we use to provide services to external customers and excludes lines used solely by us and our affiliates. It also excludes unbundled loops and includes stand-alone Mass Markets broadband subscribers. We count lines when we install the service. Other companies may use different methodologies.    

(4) Represents the total number of units capable of receiving our broadband services at period end. Other companies may use different methodologies to count their broadband enabled units.


Description of Non-GAAP Metrics

Pursuant to Regulation G, the company is hereby providing definitions of non-GAAP financial metrics and reconciliations to the most directly comparable GAAP measures.

The following describes and reconciles those financial measures as reported under accounting principles generally accepted in the United States (GAAP) with those financial measures as adjusted by the items detailed below and presented in the accompanying news release. These calculations are not prepared in accordance with GAAP and should not be viewed as alternatives to GAAP. In keeping with its historical financial reporting practices, the company believes that the supplemental presentation of these calculations provides meaningful non-GAAP financial measures to help investors understand and compare business trends among different reporting periods on a consistent basis.

We use the term Special Items as a non-GAAP measure to describe items that impacted a period’s statement of operations for which investors may want to give special consideration due to their magnitude, nature or both. We do not call these items non-recurring because, while some are infrequent, others may recur in future periods.

We use the term “Modified” basis on certain metrics herein, which reflect amounts modified to assume the Latin American business and 20-state ILEC business divestitures took place on January 1, 2021 and excluding financial impacts related to the Federal Communications Commission’s Connect America Fund (“CAF”) Phase II program, which lapsed on December 31, 2021, each excluding the effects of special items. The modified historical financial information has not been prepared in conformity with Article XI of Regulation S-X and does not constitute pro forma financial information.

Adjusted EBITDA ($) is defined as net income (loss) from the Statements of Operations before income tax (expense) benefit, total other income (expense), depreciation and amortization, stock-based compensation expense and impairments.

Adjusted EBITDA Margin ({515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}) is defined as Adjusted EBITDA divided by total revenue.

Management believes that Adjusted EBITDA and Adjusted EBITDA Margin are relevant and useful metrics to provide to investors, as they are an important part of our internal reporting and are key measures used by management to evaluate profitability and operating performance of Lumen and to make resource allocation decisions. Management believes such measures are especially important in a capital-intensive industry such as telecommunications. Management also uses Adjusted EBITDA and Adjusted EBITDA Margin (and similarly uses these terms excluding Special Items) to compare our performance to that of our competitors and to eliminate certain non-cash and non-operating items in order to consistently measure from period to period our ability to fund capital expenditures, fund growth, service debt and determine bonuses. Adjusted EBITDA excludes non-cash stock compensation expense and impairments because of the non-cash nature of these items. Adjusted EBITDA also excludes interest income, interest expense and income taxes, and in our view constitutes an accrual-based measure that has the effect of excluding period-to-period changes in working capital and shows profitability without regard to the effects of capital or tax structure. Adjusted EBITDA also excludes depreciation and amortization expense because these non-cash expenses primarily reflect the impact of historical capital investments, as opposed to the cash impacts of capital expenditures made in recent periods, which may be evaluated through cash flow measures. Adjusted EBITDA further excludes the gain (or loss) on extinguishment and modification of debt and other income (expense), net, because these items are not related to the primary business operations of Lumen.

There are material limitations to using Adjusted EBITDA as a financial measure, including the difficulty associated with comparing companies that use similar performance measures whose calculations may differ from our calculations. Additionally, by excluding the above-listed items, Adjusted EBITDA may exclude items that investors believe are important components of our performance. Adjusted EBITDA and Adjusted EBITDA Margin (either with or without Special Items) should not be considered a substitute for other measures of financial performance reported in accordance with GAAP.

Unlevered Cash Flow is defined as net cash provided by (used in) operating activities less capital expenditures, plus cash interest paid and less interest income, all as disclosed in the Statements of Cash Flows or the Statements of Operations. Management believes that Unlevered Cash Flow is a relevant metric to provide to investors, because it reflects the operational performance of Lumen and, measured over time, enables management and investors to monitor the underlying business’ growth pattern and ability to generate cash. Unlevered Cash Flow excludes cash used for acquisitions and debt service and the impact of exchange rate changes on cash and cash equivalents balances.

There are material limitations to using Unlevered Cash Flow to measure our cash performance as it excludes certain material items that investors may believe are important components of our cash flows. Comparisons of our Unlevered Cash Flow to that of some of our competitors may be of limited usefulness since Lumen does not currently pay a significant amount of income taxes due to net operating loss carryforwards, and therefore, currently generates higher cash flow than a comparable business that does pay income taxes. Additionally, this financial measure is subject to variability quarter over quarter as a result of the timing of payments related to accounts receivable, accounts payable, payroll and capital expenditures. Unlevered Cash Flow should not be used as a substitute for net change in cash, cash equivalents and restricted cash in the Consolidated Statements of Cash Flows.

Free Cash Flow is defined as net cash provided by (used in) operating activities less capital expenditures as disclosed in the Statements of Cash Flows. Management believes that Free Cash Flow is a relevant metric to provide to investors, as it is an indicator of our ability to generate cash to service our debt. Free Cash Flow excludes cash used for acquisitions, principal repayments and the impact of exchange rate changes on cash and cash equivalents balances.

There are material limitations to using Free Cash Flow to measure our performance as it excludes certain material items that investors may believe are important components of our cash flows. Comparisons of our Free Cash Flow to that of some of its competitors may be of limited usefulness since Lumen does not currently pay a significant amount of income taxes due to net operating loss carryforwards, and therefore, generates higher cash flow than a comparable business that does pay income taxes. Additionally, this financial measure is subject to variability quarter over quarter as a result of the timing of payments related to interest expense, accounts receivable, accounts payable, payroll and capital expenditures. Free Cash Flow should not be used as a substitute for net change in cash, cash equivalents and restricted cash on the Consolidated Statements of Cash Flows.

For further information on our use of Modified Revenue and Modified Adjusted EBITDA, see page 1 and 2 of this release, our current Report on Form 8-K filed with the U.S. Securities and Exchange Commission on Jan. 27, 2023 and the Financial Trending Schedule available at ir.lumen.com.

Lumen Technologies, Inc.

Non-GAAP Special Items

(UNAUDITED)

($ in millions)






Actual QTD


Actual YTD

Special Items Impacting Adjusted EBITDA

4Q22

4Q21


4Q22

4Q21

Consumer and other litigation

$         —

(3)


$         (3)

16

Severance

10

3


12

3

Gain on sale of businesses(1)

(180)

—


(773)

—

Loss on disposal groups held for sale

700

—


700

—

Transaction and separation costs(2)

53

19


219

37

Real estate transactions(3)

—

—


—

(40)

Total Special Items impacting Adjusted EBITDA

$      583

19


$      155

16








Actual QTD


Actual YTD

Special Items Impacting Net (Loss) Income

4Q22

4Q21


4Q22

4Q21

Consumer and other litigation

$         —

(3)


$         (3)

16

Impairment of goodwill

3,271

—


3,271

—

Gain on sale of businesses(1)

(180)

—


(773)

—

Loss on disposal groups held for sale

700

—


700

—

Gain on early retirement of debt(4)

(205)

—


(214)

(8)

Severance

10

3


12

3

Transaction and separation costs(2)

53

19


219

37

Real estate transactions(3)

—

—


—

(40)

Income from transition and separation services(5)

(82)

—


(152)

—

Total Special Items impacting Net (Loss) Income

3,567

19


3,060

8

Income tax effect of Special Items(6)

(73)

(5)


52

(2)

Total Special Items impacting Net (Loss) Income, net of tax

$   3,494

14


$   3,112

6





(1) Reflects (i) the pre-tax gain of $597 million recorded in operating income as a result of our Latin American business divestiture completed August 1, 2022 and (ii) the pre-tax gain of $176 million recorded in operating income as a result of our 20-state ILEC business divestiture completed October 3, 2022, subject to certain post-closing adjustments.

(2) Transaction and separation costs associated with (i) the sale of our Latin American business on August 1, 2022, (ii) the sale of our 20-state ILEC business on October 3, 2022, (iii) the exclusive arrangement to divest Lumen’s operations in Europe, the Middle East and Africa (the “EMEA business”) announced on November 2, 2022 and (iv) our evaluation of other potential transactions.

(3) Real estate transactions include the Q3 2021 (gain) on sale of real estate, net of impairment charges or acceleration of costs associated with our real estate rationalization program.

(4) Reflects a gain as a result of (i) $4.4 billion in early debt retirement in Q4 2022, (ii) $2.3 billion in early debt retirement in Q3 2022 and (iii) $1.1 billion in early debt retirement in Q1 2021. There were no comparable gains or losses during Q2 2022, Q1 2022, Q4 2021, Q3 2021, or Q2 2021.

(5) Income from transition and separation services includes charges we billed for transition services and IT professional services provided to the purchasers in connection with our divestitures.

(6) Tax effect calculated using the annualized effective statutory tax rate, excluding any non-recurring discrete items, which was 24.6{515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502} for all quarters of 2022 and 24.5{515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502} for all quarters of 2021.

Lumen Technologies, Inc.

Non-GAAP Cash Flow Reconciliation

(UNAUDITED)

($ in millions)


Actual QTD


Actual YTD


4Q22

4Q21


4Q22

4Q21

Net cash provided by operating activities

$           841

1,607


$       4,735

6,501

Capital expenditures

(833)

(848)


(3,016)

(2,900)

Free Cash Flow

8

759


1,719

3,601

Cash interest paid

273

343


1,365

1,487

Interest income

(17)

(2)


(25)

(2)

Unlevered Cash Flow

$           264

$       1,100


$       3,059

$       5,086







Free Cash Flow

$               8

$           759


$       1,719

$       3,601

Add back: Severance(1)

7

6


37

70

Add back: Consumer and other litigation(1)

—

(3)


—

47

Add back: Pension contributions(1)

—

—


319

—

Add back: Transaction and separation costs(1)

142

11


282

20

Add back: Real estate transactions(1)

—

3


—

4

Remove: Income from transition and separation services(1)

(31)

—


(97)

—

Free Cash Flow excluding cash Special Items

$           126

$           776


$       2,260

$       3,742







Unlevered Cash Flow

$           264

$       1,100


$       3,059

$       5,086

Add back: Severance(1)

7

6


37

70

Add back: Consumer and other litigation(1)

—

(3)


—

47

Add back: Pension contributions(1)

—

—


319

—

Add back: Transaction and separation costs(1)

142

11


282

20

Add back: Real estate transactions(1)

—

3


—

4

Remove: Income from transition and separation services(1)

(31)

—


(97)

—

Unlevered Cash Flow excluding cash Special Items

$           382

$       1,117


$       3,600

$       5,227







(1) Refer to Non-GAAP Special Items table for details of the Special Items impacting cash included above.



Lumen Technologies, Inc.

Adjusted EBITDA Non-GAAP Reconciliation

(UNAUDITED)

($ in millions)


Actual QTD


Actual YTD


4Q22

4Q21


4Q22

4Q21

Net (loss) income

$  (3,069)

508


$  (1,548)

2,033

Income tax (benefit) expense

(113)

171


557

668

Total other expense, net

(102)

482


1,086

1,584

Depreciation and amortization expense

796

877


3,239

4,019

Stock-based compensation expense

27

31


98

120

Goodwill impairment

3,271

—


3,271

—

Adjusted EBITDA

$       810

2,069


$    6,703

8,424







Add back: Severance(1)

$         10

3


$         12

3

Add back: Consumer and other litigation(1)

—

(3)


(3)

16

Remove: Gain on sale of businesses(1)

(180)

—


(773)

—

Add back: Loss on disposal groups held for sale

700

—


700

—

Add back: Transaction and separation costs(1)

53

19


219

37

Add back: Real estate transactions(1)

—

—


—

(40)

Adjusted EBITDA excluding Special Items

$    1,393

2,088


$    6,858

8,440







Total revenue

$    3,800

4,847


$ 17,478

19,687







Adjusted EBITDA margin

21.3 {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

42.7 {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}


38.4 {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

42.8 {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

Adjusted EBITDA margin excluding Special Items

36.7 {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

43.1 {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}


39.2 {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}

42.9 {515baef3fee8ea94d67a98a2b336e0215adf67d225b0e21a4f5c9b13e8fbd502}







(1) Refer to Non-GAAP Special Items table for details of the Special Items included above.






Outlook

To enhance the information in our outlook with respect to non-GAAP metrics, we are providing a range for certain GAAP measures that are components of the reconciliation of the non-GAAP metrics. The provision of these ranges is in no way meant to indicate that Lumen is explicitly or implicitly providing an outlook on those GAAP components of the reconciliation. In order to reconcile the non-GAAP financial metric to GAAP, Lumen has to use ranges for the GAAP components that arithmetically add up to the non-GAAP financial metric. While Lumen believes that it has used reasonable assumptions in connection with developing the outlook for its non-GAAP financial metrics, it fully expects that the ranges used for the GAAP components will vary from actual results. We will consider our outlook of non-GAAP financial metrics to be accurate if the specific non-GAAP metric is met or exceeded, even if the GAAP components of the reconciliation are different from those provided in an earlier reconciliation.

Lumen Technologies, Inc.

2023 OUTLOOK (1) (2) (3) (4) (5)

(UNAUDITED)

($ in millions)





Adjusted EBITDA Outlook




Twelve Months Ended December 31, 2023





Range


Low


High

Net income

$                     185


670

Income tax expense

65


235

Total other expense

1,100


900

Depreciation and amortization expense

3,100


2,900

Stock-based compensation expense

150


95

Adjusted EBITDA

$                  4,600


$                  4,800





Free Cash Flow Outlook




Twelve Months Ended December 31, 2023





Range


Low


High

Net cash provided by operating activities

$                  2,900


3,300

Capital expenditures

(2,900)


(3,100)

Free Cash Flow

$                       —


200


(1) For definitions of non-GAAP metrics and reconciliation to GAAP figures, see the above schedules and our Investor Relations website.


(2) Outlook measures in this chart (i) exclude the effects of Special Items, future changes in our operating or capital allocation plans, unforeseen changes in regulation, laws or litigation, and other unforeseen events or circumstances impacting our financial performance and (ii) speak only as of Feb. 7, 2023. See “Forward-Looking Statements.”


(3) Includes accounting impacts of assets and liabilities held for sale and assumes the proposed sale of Lumen’s EMEA business is not completed during 2023.


(4) Assumes no discretionary pension plan contributions during 2023.


(5) Excludes the estimated $900 million to $1 billion impact of taxes related to our divestitures completed on Aug. 1, 2022 and Oct. 3, 2022.

SOURCE Lumen Technologies

Decisions by CVS and Optum Panicked Thousands of Their Sickest Patients

Decisions by CVS and Optum Panicked Thousands of Their Sickest Patients

NEW YORK — The fear started when a few patients saw their nurses and dietitians posting job searches on LinkedIn.

Word spread to Facebook groups, and patients started calling Coram CVS, a major U.S. supplier of the compounded IV nutrients on which they rely for survival. To their dismay, CVS Health confirmed the rumors on June 1: It was closing 36 of the 71 branches of its Coram home infusion business and laying off about 2,000 nurses, dietitians, pharmacists, and other employees.

Many of the patients left in the lurch have life-threatening digestive disorders that render them unable to eat or drink. They depend on parenteral nutrition, or PN — in which amino acids, sugars, fats, vitamins, and electrolytes are pumped, in most cases, through a specialized catheter directly into a large vein near the heart.

The day after CVS’ move, another big supplier, Optum Rx, announced its own consolidation. Suddenly, thousands would be without their highly complex, shortage-plagued, essential drugs and nutrients.

“With this kind of disruption, patients can’t get through on the phones. They panic,” said Cynthia Reddick, a senior nutritionist who was let go in the CVS restructuring.

“It was very difficult. Many emails, many phone calls, acting as a liaison between my doctor and the company,” said Elizabeth Fisher Smith, a 32-year-old public health instructor in New York City, whose Coram branch closed. A rare medical disorder has forced her to rely on PN for survival since 2017. “In the end, I got my supplies, but it added to my mental burden. And I’m someone who has worked in health care nearly my entire adult life.”

CVS had abandoned most of its less lucrative market in home parenteral nutrition, or HPN, and “acute care” drugs like IV antibiotics. Instead, it would focus on high-dollar, specialty intravenous medications like Remicade, which is used for arthritis and other autoimmune conditions.

Home and outpatient infusions are a growing business in the United States, as new drugs for chronic illness enable patients, health care providers, and insurers to bypass in-person treatment. Even the wellness industry is cashing in, with spa storefronts and home hydration services.

But while reimbursement for expensive new drugs has drawn the interest of big corporations and private equity, the industry is strained by a lack of nurses and pharmacists. And the less profitable parts of the business — as well as the vulnerable patients they serve — are at serious risk.

This includes the 30,000-plus Americans who rely for survival on parenteral nutrition, which has 72 ingredients. Among those patients are premature infants and post-surgery patients with digestive problems, and people with short or damaged bowels, often the result of genetic defects.

While some specialty infusion drugs are billed through pharmacy benefit managers that typically pay suppliers in a few weeks, medical plans that cover HPN, IV antibiotics, and some other infusion drugs can take 90 days to pay, said Dan Manchise, president of Mann Medical Consultants, a home care consulting company.

In the 2010s, CVS bought Coram, and Optum bought up smaller home infusion companies, both with the hope that consolidation and scale would offer more negotiating power with insurers and manufacturers, leading to a more stable market. But the level of patient care required was too high for them to make money, industry officials said.

“With the margins seen in the industry,” Manchise said, “if you’ve taken on expensive patients and you don’t get paid, you’re dead.”

In September, CVS announced its purchase of Signify Health, a high-tech company that sends out home health workers to evaluate billing rates for “high-priority” Medicare Advantage patients, according to an analyst’s report. In other words, as CVS shed one group of patients whose care yields low margins, it was spending $8 billion to seek more profitable ones.

CVS “pivots when necessary,” spokesperson Mike DeAngelis told KHN. “We decided to focus more resources on patients who receive infusion services for specialty medications” that “continue to see sustained growth.” Optum declined to discuss its move, but a spokesperson said the company was “steadfastly committed to serving the needs” of more than 2,000 HPN patients.

DeAngelis said CVS worked with its HPN patients to “seamlessly transition their care” to new companies.

However, several Coram patients interviewed about the transition indicated it was hardly smooth. Other HPN businesses were strained by the new demand for services, and frightening disruptions occurred.

Smith had to convince her new supplier that she still needed two IV pumps — one for HPN, the other for hydration. Without two, she’d rely partly on “gravity” infusion, in which the IV bag hangs from a pole that must move with the patient, making it impossible for her to keep her job.

“They just blatantly told her they weren’t giving her a pump because it was more expensive, she didn’t need it, and that’s why Coram went out of business,” Smith said.

Many patients who were hospitalized at the time of the switch — several inpatient stays a year are not unusual for HPN patients — had to remain in the hospital until they could find new suppliers. Such hospitalizations typically cost at least $3,000 a day.

“The biggest problem was getting people out of the hospital until other companies had ramped up,” said Dr. David Seres, a professor of medicine at the Institute of Human Nutrition at Columbia University Medical Center. Even over a few days, he said, “there was a lot of emotional hardship and fear over losing long-term relationships.”

To address HPN patients’ nutritional needs, a team of physicians, nurses, and dietitians must work with their supplier, Seres said. The companies conduct weekly bloodwork and adjust the contents of the HPN bags, all under sterile conditions because these patients are at risk of blood infections, which can be grave.

As for Coram, “it’s pretty obvious they had to trim down business that was not making money,” Reddick said, adding that it was noteworthy both Coram and Optum Rx “pivoted the same way to focus on higher-dollar, higher-reimbursement, high-margin populations.”

“I get it, from the business perspective,” Smith said. “At the same time, they left a lot of patients in a not great situation.”

***

Decisions by CVS and Optum Panicked Thousands of Their Sickest Patients
Elizabeth Fisher Smith sits with husband Matt and dogs Caspian and Gretl at the table where she spends hours every day preparing IV hydration and nutrition, on which she depends to survive.(Arthur Allen / KHN)

Smith shares a postage-stamp Queens apartment with her husband, Matt; his enormous flight simulator (he’s an amateur pilot); cabinets and fridges full of medical supplies; and two large, friendly dogs, Caspian and Gretl. On a recent morning, she went about her routine: detaching the bag of milky IV fluid that had pumped all night through a central line implanted in her chest, flushing the line with saline, injecting medications into another saline bag, and then hooking it through a paperback-sized pump into her central line.

Smith has a connective tissue disorder called Ehlers-Danlos syndrome, which can cause many health problems. As a child, Smith had frequent issues such as a torn Achilles tendon and shoulder dislocations. In her 20s, while working as an EMT, she developed severe gut blockages and became progressively less able to digest food. In 2017, she went on HPN and takes nothing by mouth except for an occasional sip of liquid or bite of soft food, in hopes of preventing the total atrophy of her intestines. HPN enabled her to commute to George Washington University in Washington, D.C., where in 2020 she completed a master’s in public health.

On days when she teaches at LaGuardia Community College — she had 35 students this semester — Smith is up at 6 a.m. to tend to her medical care, leaves the house at 9:15 for class, comes home in the afternoon for a bag of IV hydration, then returns for a late afternoon or evening class. In the evening she gets more hydration, then hooks up the HPN bag for the night. On rare occasions she skips the HPN, “but then I regret it,” she said. The next day she’ll have headaches and feel dizzy, sometimes losing her train of thought in class.

Smith describes a “love-hate relationship” with HPN. She hates being dependent on it, the sour smell of the stuff when it spills, and the mountains of unrecyclable garbage from the 120 pounds of supplies couriered to her apartment weekly. She worries about blood clots and infections. She finds the smell of food disconcerting; Matt tries not to cook when she’s home. Other HPN patients speak of sudden cravings for pasta or Frosted Mini-Wheats.

Yet HPN “has given me my life back,” Smith said.

She is a zealous self-caretaker, but some dangers are beyond her control. IV feeding over time is associated with liver damage. The assemblage of HPN bags by compounding pharmacists is risky. If the ingredients aren’t mixed in the right order, they can crystallize and kill a patient, said Seres, Smith’s doctor.

He and other doctors would like to transition patients to food, but this isn’t always possible. Some eventually seek drastic treatments such as bowel lengthening or even transplants of the entire digestive tract.

“When they run out of options, they could die,” said Dr. Ryan Hurt, a Mayo Clinic physician and president of the American Society for Parenteral and Enteral Nutrition.

***

And then there are the shortages.

In 2017, Hurricane Maria crippled dozens of labs and factories making IV components in Puerto Rico; next came the covid-19 emergency, which shifted vital supplies to gravely ill hospital patients.

Prices for vital HPN ingredients can fluctuate unpredictably as companies making them come and go. For example, in recent years the cost of the sodium acetate used as an electrolyte in a bag of HPN ballooned from $2 to $25, then briefly to $300, said Michael Rigas, a co-founder of the home infusion pharmacy KabaFusion.

“There may be 50 different companies involved in producing everything in an HPN bag,” Rigas said. “They’re all doing their own thing — expanding, contracting, looking for ways to make money.” This leaves patients struggling to deal with various shortages from saline and IV bags to special tubing and vitamins.

“In the last five years I’ve seen more things out of stock or on shortage than the previous 35 years combined,” said Rigas.

The sudden retrenchment of CVS and Optum Rx made things worse. Another, infuriating source of worry: the steady rise of IV spas and concierge services, staffed by moonlighting or burned-out hospital nurses, offering IV vitamins and hydration to well-off people who enjoy the rush of infusions to relieve symptoms of a cold, morning sickness, a hangover, or just a case of the blahs.

In January, infusion professionals urged FDA Commissioner Robert Califf to examine spa and concierge services’ use of IV products as an “emerging contributing factor” to shortages.

The FDA, however, has little authority over IV spas. The Federal Trade Commission has cracked down on some spa operations — for unsubstantiated health claims rather than resource misuse.

Bracha Banayan’s concierge service, called IVDRIPS, started in 2017 in New York City and now employs 90 people, including 60 registered nurses, in four states, she said. They visit about 5,000 patrons each year, providing IV hydration and vitamins in sessions of an hour or two for up to $600 a visit. The goal is “to hydrate and be healthy” with a “boost that makes us feel better,” Banayan said.

Although experts don’t recommend IV hydration outside of medical settings, the market has exploded, Banayan said: “Every med spa is like, ‘We want to bring in IV services.’ Every single paramedic I know is opening an IV center.”

Matt Smith, Elizabeth’s husband, isn’t surprised. Educated as a lawyer, he is a paramedic who trains others at Columbia University Irving Medical Center. “You give someone a choice of go up to some rich person’s apartment and start an IV on them, or carry a 500-pound person living in squalor down from their apartment,” he said. “There’s one that’s going to be very hard on your body and one very easy on your body.”

The very existence of IV spa companies can feel like an insult.

“These people are using resources that are literally a matter of life or death to us,” Elizabeth Smith said.

Shortages in HPN supplies have caused serious health problems including organ failure, severe blisters, rashes, and brain damage.

For five months last year, Rylee Cornwell, 18 and living in Spokane, Washington, could rarely procure lipids for her HPN treatment. She grew dizzy or fainted when she tried to stand, so she mostly slept. Eventually she moved to Phoenix, where the Mayo Clinic has many Ehlers-Danlos patients and supplies are easier to access.

Mike Sherels was a University of Minnesota Gophers football coach when an allergic reaction caused him to lose most of his intestines. At times he’s had to rely on an ethanol solution that damages the ports on his central line, a potentially deadly problem “since you can only have so many central access sites put into your body during your life,” he said.

When Faith Johnson, a 22-year-old Las Vegas student, was unable to get IV multivitamins, she tried crushing vitamin pills and swallowing the powder, but couldn’t keep the substance down and became malnourished. She has been hospitalized five times this past year.

Dread stalks Matt Smith, who daily fears that Elizabeth will call to say she has a headache, which could mean a minor allergic or viral issue — or a bloodstream infection that will land her in the hospital.

Even more worrying, he said: “What happens if all these companies stop doing it? What is the alternative? I don’t know what the economics of HPN are. All I know is the stuff either comes or it doesn’t.”

Related Topics

Contact Us

Submit a Story Tip